enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. List of companies in the Chicago metropolitan area - Wikipedia

   en.wikipedia.org/wiki/List_of_companies_in_the...

   The Chicago metropolitan area – also known as "Chicagoland" – is the metropolitan area associated with the city of Chicago, Illinois, and its suburbs. [2] With an estimated population of 9.4 million people, [ 3 ] it is the third largest metropolitan area in the United States [ 4 ] and the region most connected to the city through geographic ...

3. Astellas Pharma - Wikipedia

   en.wikipedia.org/wiki/Astellas_Pharma

   Astellas Pharma office in Canada. Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd. (藤沢薬品工業株式会社 ...

4. List of largest biomedical companies by revenue - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_biomedical...

   The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.

5. Ipragliflozin - Wikipedia

   en.wikipedia.org/wiki/Ipragliflozin

   Ipragliflozin (INN, [2]: 69 trade names Suglat) is a pharmaceutical drug for treatment of type 2 diabetes. Ipragliflozin, jointly developed by Astellas Pharma and Kotobuki Pharmaceutical, was approved in Japan on January 17, 2014, [3] and in Russia on May 22, 2019. [4] Ipragliflozin is a Sodium/glucose cotransporter 2 (SGLT2) inhibitor . [5]

6. Daiichi Sankyo - Wikipedia

   en.wikipedia.org/wiki/Daiichi_Sankyo

   Daiichi Sankyo Company, Limited (Japanese: 第一三共株式会社, Hepburn: Daiichi Sankyō Kabushiki-gaisha) is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. [3] The company owns the American pharmaceutical company American Regent.

7. OSI Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/OSI_Pharmaceuticals

   OSI Pharmaceuticals, Inc. was an American pharmaceutical company formerly based in Long Island, New York with facilities in Colorado, New Jersey and the United Kingdom. On Sunday, May 16, 2010 OSI agreed to be acquired by Japan-based, TSE-listed Astellas Pharma for $4.0 billion. [4] The deal was closed on June 9, 2010.